Abstract:The TP63 gene, a member of the TP53 gene family, encodes several isoforms with (TAp63) or without (ΔNp63) transactivating properties. Whereas the role of p63 in the normal development of squamous epithelia is well established, its function in other cell types remains to be elucidated. Here, we have analysed the expression of TA and ΔNp63 isoforms in liver cells, by using both primary hepatocytes from wild type and p53-null mice and three human hepatocellular carcinoma (HCC) cell lines, according to the transformation state and the TP53 status of the cells. We observed the expression of ΔNp63 isoforms only in a p53-null context. On the other hand, the expression of TAp63 isoforms was restricted to the HCC cell lines, whatever the TP53 status. We then studied the expression of TP63 upon genotoxic treatment. When treated with UVB or H2O2, hepatocytes did not exhibit any change in p63 mRNA level. At the opposite, upon treatment with topoisomerase II inhibitors (doxorubicin or etoposide), the expression of TAp63 isoforms was clearly induced, independently of the TP53 status of cells. The same treatment did not induce any variation in the expression of ΔNp63 isoforms, both at mRNA and protein levels. In HCC cell lines, doxorubicin or etoposide treatment also resulted in an increase of TAp63 transcripts only. This increase was accompanied by an increase in the intracellular level of TAp63 alpha protein. In parallel, we observed an upregulation of some p53-target genes related to cell cycle regulation, such as WAF1/CIP1, PIG3, 14-3-3σ or GADD45, independently of the TP53 status of cells. In conclusion, we report for the first time that TA and ΔNp63 alpha proteins are present in liver cells. Furthermore, our results suggest that p63 may partially substitute for wild-type p53, in counteracting uncontrolled liver cell proliferation in response to certain forms of DNA-damage.

The expression of TA and ΔNp63 are regulated by different mechanisms in liver cells

TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expression

Elevated ΔNp63α Levels Facilitate Epidermal and Biliary Oncogenic Transformation

TAp63γ Enhances Nucleotide Excision Repair Through Transcriptional Regulation of DNA Repair Genes

p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway

Delta Np63 Alpha And Tap63 Alpha Regulate Transcription Of Genes With Distinct Biological Functions In Cancer And Development

How the TP53 Family Proteins TP63 and TP73 Contribute to Tumorigenesis: Regulators and Effectors

Repression of Wnt/β-catenin response elements by p63 (TP63)

ΔNp63α Modulates Phosphorylation of P38 MAP Kinase in Regulation of Cell Cycle Progression and Cell Growth.

The Dual Role of P63 in Cancer

P63 regulates tubular formation via epithelial-to-mesenchymal transition

TP53 Supports Basal-Like Differentiation of Mammary Epithelial Cells by Preventing Translocation of Deltanp63 into Nucleoli

Genome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stress

Regulation of skin aging and heart development by TAp63

p63-related signaling at a glance

P63 in health and cancer

A double dealing tale of p63: an oncogene or a tumor suppressor

Identification and functional characterization of two new transcriptional variants of the human p63 gene

The Δ40p53 isoform inhibits p53-dependent eRNA transcription and enables regulation by signal-specific transcription factors during p53 activation

Distinct interactors define the p63 transcriptional signature in epithelial development or cancer

Ccdc3: A New P63 Target Involved in Regulation of Liver Lipid Metabolism.